INTERNATIONAL PATENT: HUAYAO JIYUAN (SHENZHEN) PHARMACEUTICAL CO., LTD., 华药纪元（深圳）医药有限公司 FILES APPLICATION FOR "USE OF TAFAMIDIS AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREVENTION, ALLEVIATION, OR TREATMENT OF DISEASES ASSOCIATED WITH HIF-2Α"

Posted On: 2025-10-26

GENEVA, Oct. 26 -- HUAYAO JIYUAN (SHENZHEN) PHARMACEUTICAL CO., LTD. (Building 3, Unit 1902, Hepalink Biopharmaceutical Eco-Park, No. 1 Rongtian South Road, Jinsha Community, Kengzi Subdistrict, Pingshan DistrictShenzhen, Guangdong 518122), 华药纪元（深圳）医药有限公司 (中国广东省深圳市坪山区坑梓街道金沙社区荣田南路1号海普瑞生物医药生态园厂房3栋1902) filed a patent application (PCT/CN2025/089203) for "USE OF TAFAMIDIS AND PHARMACEUTICALLY A...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: HUAYAO JIYUAN (SHENZHEN) PHARMACEUTICAL CO., LTD., 华药纪元（深圳）医药有限公司 FILES APPLICATION FOR "USE OF TAFAMIDIS AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREVENTION, ALLEVIATION, OR TREATMENT OF DISEASES ASSOCIATED WITH HIF-2Α"